NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase’s pipeline includes therapeutic candidates ...
Use this information to figure out if this company is an ideal customer for you.
617.430.7576
2730 Sidney Street
Pittsburgh, 15219
51 - 200 Employees
$1M - $5M
linkedin.com/company/neubase-therapeutics
NeuBase Therapeutics Inc.'s CEO is Dietrich Stephan
NeuBase Therapeutics Inc.'s HQ is located at 2730 Sidney Street, Pittsburgh
NeuBase Therapeutics Inc.'s phone number is 617.430.7576
NeuBase Therapeutics Inc.'s official website is neubasetherapeutics.com
NeuBase Therapeutics Inc.'s revenue is $1M - $5M
NeuBase Therapeutics Inc. has 51 - 200 employees
NeuBase Therapeutics Inc. is in the industry of: Pharmaceuticals
